Aarvik Therapeutics

Aarvik Therapeutics is exploring exciting new molecules with improved therapeutic indices for multiple tumor targets by combining a novel modular antibody platform with various target mechanisms. Aarvik has developed a disruptive antibody engineering platform capable of creating functional blocking antibodies, ADCs, and other modalities.